Consensus Grifols, S.A.

Equities

GRF

ES0171996087

Pharmaceuticals

Market Closed - BME Other stock markets 16:35:27 15/05/2026 BST			5-day change	1st Jan Change
9.092 ^EUR	-0.92%		+1.70%	-15.03%

05-11	European Equities Traded in the US as American Depositary Receipts Start Week on Flat Note in Monday Trading	MT
05-08	Grifols: FCFs didn't impress; rebuilding trust isn't going to be easy

Evolution of the Average Target: Grifols, S.A.

Evolution of the Target Price: Grifols, S.A.

Changes in Analyst Recommendations: Grifols, S.A.

0d241adad77c4d5a9.sCBPYOUVGtxoMODOYKDiOeGeeOwU6QlJJHhttgxs4Vk.hWE9OK4jYKoaQ6H_ONDTFND7P7k5qlEDUDoC7F4zggvnaT0P13R2lBtnpQ~c4be3df2074b1e2595a282fe701b3eb4

Analysts' recommendations: Grifols, S.A.

05-08	Grifols: FCFs didn't impress; rebuilding trust isn't going to be easy
04-06	AlphaValue/Baader Europe Reduces Grifols' PT, Keeps at Buy	MT
04-06	AlphaValue/Baader Europe Lowers Grifols Forecasts Amid Lack of FY26 Sales Growth Guidance	MT
04-06	Grifols: May struggle to walk the talk
03-27	Grifols: IPO plans for a subsidiary don't smell right
03-10	Morgan Stanley Downgrades Grifols to Equalweight, Cuts PT	MT
02-27	Grifols: Decent end to 2025, but suspicions rise over future execution abilities
11-06	Grifols lifts 2025 targets but fibrinogen delay and forex drag weigh on outlook
11-05	Invest Securities raises target price for Grifols
11-05	Spanish stocks - Factors to watch on Nov 5	RE
09/10/25	Spain's High Court summons Gotham City, GIP managers for market-related offence regarding Grifols	RE
29/09/25	Grifols creates strategy committee to advise board	RE
17/09/25	Alantra Equities Upgrades Grifols to Buy, Raises PT	MT
26/08/25	AlphaValue/Baader Europe Upgrades Grifols to Buy, Lifts PT	MT
31/07/25	BofA Keeps Grifols at Buy as Strong Q2 Offsets Currency Headwinds	MT
30/07/25	Grifols: Exhibiting confidence by reinstating dividends
28/05/25	Barclays Keeps Grifols at Overweight on Growing Positive Momentum	MT
27/05/25	Grifols: Governance and operational improvements are worthy of notice
14/05/25	AlphaValue/Baader Europe Keeps Grifols at Buy After Q1 Beat	MT
13/05/25	Grifols: A healthy Q1 impressed investors
04/03/25	Grifols: Invest Securities raises its price target
27/02/25	Grifols: Q4 24: Investors impressed with FCF generation and governance-related announcements
28/01/25	Barclays Sees Upside Share Potential for Grifols Despite Price Target Cut Amid Headline Risks	MT
08/11/24	Grifols: Invest Securities remains Buy, adjusts its target
08/11/24	Grifols: No negative surprise in Q3 was good enough for the market

More recommendations

Sector Comparison:

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	GRIFOLS, S.A.					+61.08%
	REGENERON PHARMACEUTICALS, INC.					+25.36%
	UCB					+21.61%
	SAMSUNG BIOLOGICS CO.,LTD.					+52.47%
	CSL LIMITED					+51.27%
	BIOGEN INC.					+13.64%
	MODERNA, INC.					-11.57%
	INCYTE CORPORATION					+13.84%
	INNOVENT BIOLOGICS, INC.					+41.94%
	SWEDISH ORPHAN BIOVITRUM AB					+6.39%
	Average					+27.60%
	Weighted average by Cap.					+28.03%

See all sector consensus

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

9.092EUR

Average target price

14.65EUR

Spread / Average Target

+61.08%

High Price Target

21.20EUR

Spread / Highest target

+133.17%

Low Price Target

9.000EUR

Spread / Lowest Target

-1.01%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

alphavalue	Abhishek Raval
AlphaValue/Baader Europe
Morgan Stanley
Alantra Equities
Invest Securities
JPMorgan Chase
Credit Suisse
Citigroup
Deutsche Bank Securities
HSBC